10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
Bispecific Playgrounds? No, Factory Floors
Developers Prepare for Future Biologics Work by Exploring a Multitude of Antibody Formats
Vertex’s David Altshuler Humanizes Drug Discovery
Lessons from Vertex’s Small Molecule Drug Development Program for Cystic Fibrosis
GEN Roundup: Multiplexed Immunoassays: Small Samples, Big Pictures
Taking in "Everything All at Once" Can Reveal Meaningful Biological Patterns and Drug Targets
For full access to this article login to GEN Select now.
Flip the DNA Nanoswitch, Power the Clinical App
A Molecular Interaction Detection Platform Uses a Gel-based Readout
- It may not be long before nanoscale devices that function with the flip of a DNA nanoswitch are available in the clinical setting. They could be used to easily and cost-effectively detect very low levels of biomarkers for diagnostic purposes, or to deliver therapeutic cargo when prompted to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.